A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants
7d agoen
From the article
Conditions : Fluid Retention Due to Heart Failure Interventions : Drug: [14C]HRS-9057 Sponsors : Fujian Shengdi Pharmaceutical Co., Ltd. Not yet recruiting
Continue reading on clinicaltrials.gov
Comments
Sign in to join the conversation.
No comments yet. Be the first.